Orion Corporation (pharmaceutical company)
Finnish pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Orion Pharma?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
This article is about the pharmaceutical company. For other companies named Orion, see Orion (disambiguation).
Orion Corporation (Finnish: Orion Oyj),[2][3] founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.[4]
Quick Facts Native name, Company type ...
Native name | Orion Oyj |
---|---|
Company type | Julkinen osakeyhtiö |
Nasdaq Helsinki: ORNAV,ORNBV | |
Industry | Pharmaceutical industry |
Founded | 21 September 1917; 106 years ago (1917-09-21) |
Headquarters | Espoo, Finland |
Key people | Liisa Hurme (President and CEO), Mikael Silvennoinen (Chairman) |
Products | Pharmaceuticals and active pharmaceutical ingredients |
Revenue | €1.041 billion (2021) |
€243.3 million (2021) | |
€193.8 million (2021) | |
Total assets | €1.114 billion (2021) |
Total equity | €747.9 million (2021) |
Number of employees | 3,364 (2021) |
Website | www |
Footnotes / references [1] |
Close
Orion's class A and B shares are listed on the Helsinki Stock Exchange.